Premium Information is available for this item - Upgrade for $1 a day
6505-00-427-2121
Usp Levodopa Tablets
6505004272121 004272121 LARODOPA TABLETS 72356 NDC00004-0056-14
November 2023
13
Marketplace 6505-00-427-2121
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-427-2121 5+ Documents (More...)
RQST NE Updated Every Day 6505-00-427-2121 RQST Updated Every Day 6505-00-427-2121 RQST NE Related Documents
6505-00-427-2121 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-427-2121
Usp Levodopa Tablets 6505004272121 004272121 -65/fsc-6505/us 6505-00-427-2121 04493 LARODOPA https
Usp Levodopa Tablets 6505010140997 Documents 6505-01-303 fsc-6505/us 6505-01-014-0998 014-0997 6505-00-427-2121
DAC 4 LARODOPA TABLETS https//www.nsnlookup.com DAC 4 LARODOPA 1 DAC 4 LARODOPA TABLETS 04493 RNCC 5
Usp Levodopa Tablets 6505004272121 004272121 /fsg-65/fsc-6505/us 6505-00-189-4761 Usp Levodopa
Usp Levodopa Tablets 6505004272121 004272121 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-427-
Levodopa Tablets 6505331899240331899240 Numbers Related to 6505-00-279-7685 6505-33-189-9240 https 6505004272121
/fsg-65/fsc-6505/us 6505-00-427-2121 Usp Levodopa Tablets 6505004272121 004272121 $1 a day Upgrade your
6505013160266013160266 04493 LARODOPA TABLETS RNCC 5 RNVC 1 DAC 4 LARODOPA DAC 4 LARODOPA TABLETS 04493
Restrictions 6505-00-427-2121
6505-00-427-2121 is a Usp Levodopa Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6505-00-427-2121
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
- Kuwait (YK01)
- Effective Date:
- 1 Jan 2015
Approved Sources 6505-00-427-2121
- Part Number
- Manufacturer
- Status
- 72356
- Manufacturer
- 04493 - Hoffmann-La Roche Inc. (Active)
- Primary Buy
- Primary Buy
- NDC00004-0056-14
- 04493 - Hoffmann-La Roche Inc. (Active)
- Primary Buy
- Primary Buy
- LARODOPA TABLETS
- 04493 - Hoffmann-La Roche Inc. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-00-427-2121
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 500.000 Milligrams Levodopa Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 500.000 Tablets
- Therapeutic Equivalent [THPE]
- Larodopa By Roche Labs. Div.
NATO Stock Numbers Related to 6505-00-427-2121
Freight Information 6505-00-427-2121
6505-00-427-2121 has freight characteristics.It has a National Motor Freight Classification (NMFC) of 058770. A Sub NMFC of Z. It has a NMFC Description of DRUGS/MEDICINES/VITAMINS NOI. 6505-00-427-2121 is rated as a variable freight class when transported by Less-Than Truckload (LTL) freight. It has a Uniform Freight Classification (UFC) number of 33400 which rates the freight between FCL and LCL. 6505-00-427-2121 has a variance between NMFC and UFC when transported by rail and the description should be consulted. It has a Water Commodity Code (WCC) of 532 for ocean manifesting and military sealift. 6505-00-427-2121 is not classified as a special type of cargo when transported by water. 6505-00-427-2121 is not a consolidation and does not exceed 84" in any dimension. It should be compatible with a standard 72" Aircraft Cargo Door when transported by air.